NUCLEOLIN and cancer: In 2015, two different aptamer-conjugated QDs (TTA-1 and AS1411 aptamer) were used by Lee et al. to simultaneously demonstrate the presence of the cancer biomarkers tenascin-C and nucleolin in different cancer cell lines [101].